Page last updated: 2024-09-04

olmesartan and Cancer of Cervix

olmesartan has been researched along with Cancer of Cervix in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bakhtiari, E; Boroushaki, MT; Hosseini, A; Mousavi, SH	1

Other Studies

1 other study(ies) available for olmesartan and Cancer of Cervix

Article	Year
Synergistic, cytotoxic and apoptotic activities of olmesartan with NF-κB inhibitor against HeLa human cell line. Toxicology mechanisms and methods, 2015, Volume: 25, Issue:8 Topics: Angiotensin II Type 1 Receptor Blockers; Antineoplastic Agents; Apoptosis; Cell Line; Cell Proliferation; Cell Survival; Drug Synergism; Female; G1 Phase; HeLa Cells; Humans; Imidazoles; Inhibitory Concentration 50; Kinetics; Male; NF-kappa B; Nitriles; Sulfones; Tetrazoles; Uterine Cervical Neoplasms	2015

Article

Year

Synergistic, cytotoxic and apoptotic activities of olmesartan with NF-κB inhibitor against HeLa human cell line.

Toxicology mechanisms and methods, 2015, Volume: 25, Issue:8

Topics: Angiotensin II Type 1 Receptor Blockers; Antineoplastic Agents; Apoptosis; Cell Line; Cell Proliferation; Cell Survival; Drug Synergism; Female; G1 Phase; HeLa Cells; Humans; Imidazoles; Inhibitory Concentration 50; Kinetics; Male; NF-kappa B; Nitriles; Sulfones; Tetrazoles; Uterine Cervical Neoplasms

2015